No evidence for a role of the proximal IL-6 G/C -174 single nucleotide polymorphism in Italian patients with systemic sclerosis [1]

Journal of Cellular and Molecular Medicine

Volumn 11, Issue 4, 2007, Pages 896-898

  Beretta, Lorenzo ^a   Santaniello, Alessandro ^a   Cappiello, Francesca ^a   Barili, Morena ^a   Scorza, Raffaella ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; GUANINE; INTERLEUKIN 6;

CASE CONTROL STUDY; CAUCASIAN; FEMALE; GENETICS; GENOTYPE; HUMAN; ITALY; LETTER; MALE; MIDDLE AGED; QUESTIONNAIRE; REPRODUCIBILITY; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS;

CASE-CONTROL STUDIES; CYTOSINE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; GUANINE; HUMANS; INTERLEUKIN-6; ITALY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC;

EID: 34548169544     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00070_1.x     Document Type: Letter

References (15)

1. Sfrent-Cornateanu R, Mihai C, Balan S, Ionescu R, Moldoveanu E. The IL-6 promoter polymorphism is associated with disease activity and disability in systemic sclerosis. J Cell Mol Med. 2006 10 : 955 9.
2. Granel B, Chevillard C, Allanore Y, Arnaud V, Cabantous S, Marquet S, Weiller PJ, Durand JM, Harle JR, Grange C, Frances Y, Berbis P, Gaudart J, de Micco P, Kahan A, Dessein A. Evaluation of interleukin 13 polymorphisms in systemic sclerosis. Immunogenetics. 2006 58 : 693 9.
3. Tolusso B, Fabris M, Caporali R, Cuomo G, Isola M, Soldano F, Montecucco C, Valentini G, Ferraccioli G 238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis. Immunol Lett. 2005 96 : 103 8.
4. Beretta L, Cappiello F, Barili M, Scorza R. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis. Tissue Antigens. 2007 69 : 305 12.
5. Beretta L, Bertolotti F, Cappiello F, Barili M, Masciocchi M, Toussoun K, Caronni M, Scorza R. IL-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology. Human Immunol. 2007 68 : 603 9.
6. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998 102 : 1369 76.
7. No authors listed. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutics Criteria Committee. Arthritis Rheum. 1980 23 : 581 90.
8. Dupont WD, Plummer WD. PS power and sample size program available for free on the Internet. Controlled Clin Trials. 1997 18 : 274.
9. Uboldi de Capei MU, Dametto E, Fasano ME, Rendine S, Curtoni ES. Genotyping for cytokine polymorphisms: allele frequencies in the Italian population. Eur J Immunogenet. 2003 30 : 5 10.
10. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr., Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subset and pathogenesis. J Rheumatol. 1988 15 : 202 5.
11. Steen VD, Medsger TA Jr. The value of the Health Assessment questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum. 1997 40 : 1984 91.
12. Valentini G, Silman AJ, Veale D. Assessment of disease activity. Clin Exp Rheumatol. 2003 21 : S39 41.
13. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, Silman AJ, Allegar N, Varga J, Massa M, Wigley FM, Ingenito F, Weisman M, White B, Martin RW, McCloskey D, Moreland LW, Mayes M, Lally EV, Unanue M, Cottier DH, Weiner S, Weinstein A, Medsger TA, Andrews B, Dixon M, Furst DE. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol. 1993 20 : 1892 6.
14. Hudson M, Steele R, Canadian Scleroderma Research Group (CSRG), Baron M. Update on Indices of Disease Activity in Systemic Sclerosis. Semin Arthritis Rheum. 2007 Mar 14; doi :.
15. Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, Korn JH, Merkel PA, Rothfield N, Wigley FM, Moreland LW, Silver R, Steen VD, Weisman M, Mayes MD, Collier DH, Medsger TA Jr., Seibold JR, Relaxin Study Group; Scleroderma Clinical Trials Consortium. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol. 2005 32 : 832 40.